Acquisition expands AbCellera’s existing capabilities to unlock difficult-to-drug transmembrane proteins for antibody discovery programs VANCOUVER, British Columbia & BOSTON – (BUSINESS WIRE) – AbCellera (Nasdaq: ABCL), a technology company with… Read More
Establishes leadership position in manufacturing and commercialization of rare cannabinoids Positions InMed within large and growing consumer health and wellness cannabinoid markets Transitions InMed into revenue generating company; acquires pipeline… Read More
VANCOUVER, BC – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the manufacturing and clinical development of rare cannabinoids, today announced that Eric. A. Adams, President and… Read More
VANCOUVER, BC – Izotropic Corporation (“Izotropic” or the “Company”) (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) a Company commercializing a dedicated Breast CT (computed tomography) imaging platform, IzoView, for the more accurate… Read More
VANCOUVER, BC – Izotropic Corporation (“Izotropic” or the “Company”) (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) a Company commercializing a dedicated Breast CT (computed tomography) imaging platform, IzoView, for the more accurate… Read More
